WC Walker & Associates’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-7,264
Closed -$1.81M 69
2021
Q1
$1.81M Buy
7,264
+226
+3% +$53.9K 1.03% 36
2020
Q4
$1.63M Buy
+7,038
New +$1.62M 0.94% 38

Other funds holding AMGN

WC Walker & Associates's AMGN Position: Q2 2021 in Review

WC Walker & Associates sold out of Amgen (AMGN) in Q2 2021, closing a stake of 7,264 shares — an estimated $1.81M sold.

WC Walker & Associates first reported a position in AMGN in Q4 2020 and held it in 2 quarters. The position peaked at $1.81M in Q1 2021. 2,194 funds tracked by Wall St. Rank hold AMGN as of Q2 2021.

  • WC Walker & Associates reported no remaining Amgen position as of Q2 2021 after selling out during the quarter.
  • WC Walker & Associates sold 7,264 Amgen shares in Q2 2021, an estimated $1.81M.
  • WC Walker & Associates first reported a position in Amgen in Q4 2020 and held it in 2 quarters.
  • WC Walker & Associates's Amgen position peaked at $1.81M in Q1 2021.
  • 2,194 funds tracked by Wall St. Rank held Amgen as of Q2 2021.

Based on WC Walker & Associates's 13F filing for Q2 2021, filed 6 Jul 2021.